Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

ELIZABETH ROSELL CESPEDES

Allopathic & Osteopathic Physicians Internal Medicine

NPI
1780061499
CMS profile
5691214
Location
DECATUR, AL

General Payments · PY2019–2024

$783.60

  • Reported across 49 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$283.45

16 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $283.45 16

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Acerta Pharma LLC $144.90 9
Novo Nordisk AS $86.85 4
Exact Sciences Corporation $30.28 2
Lilly USA, LLC $21.42 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $47.17 3
PY2020 $39.46 3
PY2021 $317.31 22
PY2023 $96.21 5
PY2024 $283.45 16

Payment records · PY2024 (16)

Sorted by paying entity, then date · as published by CMS

Program year 2024 2019202020212023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
AstraZeneca Pharmaceuticals LP $15.57 01/29/2024 Food and Beverage Undisputed 01/23/2026 1105680797 CMS
AstraZeneca Pharmaceuticals LP $15.77 03/12/2024 Food and Beverage Undisputed 01/23/2026 1104621562 CMS
AstraZeneca Pharmaceuticals LP $4.62 03/12/2024 Food and Beverage Undisputed 01/23/2026 1105573311 CMS
AstraZeneca Pharmaceuticals LP $23.19 05/14/2024 Food and Beverage Undisputed 01/23/2026 1105888337 CMS
AstraZeneca Pharmaceuticals LP $15.17 07/10/2024 Food and Beverage Undisputed 01/23/2026 1104417567 CMS
AstraZeneca Pharmaceuticals LP $21.19 08/26/2024 Food and Beverage Undisputed 01/23/2026 1105477401 CMS
AstraZeneca Pharmaceuticals LP $15.38 09/04/2024 Food and Beverage Undisputed 01/23/2026 1105859238 CMS
AstraZeneca Pharmaceuticals LP $13.92 09/09/2024 Food and Beverage Undisputed 01/23/2026 1105872503 CMS
AstraZeneca Pharmaceuticals LP $20.09 11/25/2024 Food and Beverage Undisputed 01/23/2026 1104338832 CMS
Exact Sciences Corporation $14.52 02/13/2024 Food and Beverage Undisputed 01/23/2026 1114861020 CMS
Exact Sciences Corporation $15.76 06/13/2024 Food and Beverage Undisputed 01/23/2026 1114861024 CMS
Lilly USA, LLC $21.42 03/25/2024 Food and Beverage Undisputed 01/23/2026 1136158413 CMS
Novo Nordisk Inc $20.00 03/04/2024 Food and Beverage Undisputed 01/23/2026 1096617142 CMS
Novo Nordisk Inc $17.86 05/28/2024 Food and Beverage Undisputed 01/23/2026 1097126921 CMS
Novo Nordisk Inc $24.40 08/20/2024 Food and Beverage Undisputed 01/23/2026 1097541409 CMS
Novo Nordisk Inc $24.59 10/15/2024 Food and Beverage Undisputed 01/23/2026 1096886985 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2019, 2020, 2021, 2023, 2024
Source files
Dataset page · Bulk file · PY2019 , PY2020 , PY2021 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.